Gilead Sciences

John C. Martin, PhD — Chairman and Chief Executive Officer
John F. Milligan, PhD — President and Chief Operating Officer
Norbert W. Bischofberger, PhD — Executive Vice President, Research and Development and Chief Scientific Officer
Gregg H. Alton — Executive Vice President, Corporate and Medical Affairs
Kevin Young CBE — Executive Vice President, Commercial Operations
Robin L. Washington — Senior Vice President and Chief Financial Officer

John C. Martin, PhD — Chairman and Chief Executive Officer, Gilead Sciences
James M. Denny — Lead Independent Director, Gilead Sciences Board of Directors
John F. Cogan, PhD — Senior Fellow, Hoover Institution, Stanford University
Etienne F. Davignon — Minister of State Chairman, Genfina
Carla A. Hills — Chair and Chief Executive Officer, Hills & Company, International Consultants
Kevin E. Lofton — President and Chief Executive Officer, Catholic Health Initiatives
John W. Madigan — Retired Chairman and Chief Executive Officer, Tribune Company
Gordon E. Moore, PhD — Retired Chairman and Chief Executive Officer, Intel Corporation
Nicholas G. Moore — Retired Global Chairman, PricewaterhouseCoopers
Richard J. Whitley, MD — Distinguished Professor, Loeb Scholar Chair in Pediatrics, Professor of Pediatrics, Microbiology, Medicine, and Neurosurgery, University of Alabama at Birmingham
Gayle Edlund Wilson — Former Chair, Ralph M. Parsons Foundation
Per Wold-Olsen — Retired President, Human Health Intercontinental Division, Merck & Co., Inc.
George P. Shultz, PhD — Distinguished Fellow, Hoover Institution, Stanford University